TRANSLATE: Transgender and Gender Nonconforming Individuals' Access to Healthcare
NCT ID: NCT03808883
Last Updated: 2024-08-14
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
49 participants
INTERVENTIONAL
2019-02-01
2020-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Effectiveness Research to Improve the Health of Sexual and Gender Minority Patients Through Cultural Competence and Skill Training of Community Health Center Providers and Non-clinical Staff
NCT03554785
COVID-19 Testing and Vaccine Literacy for Women With Criminal Legal System Involvement
NCT05582746
Patient Priority Care for Older Adults With Multiple Chronic Conditions
NCT04510948
A Study of Overcoming Social Determinants of Health
NCT05773313
Using Lay Health Advisors to Improve Hypertension Management
NCT03515005
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
INNOVATION: This project places TGNC community members and The LGBT Center in position to lead the direction of the research project, to gain research and health advocacy skills themselves, and the ability to form a cohort that will continue to operate beyond this pilot project. In Cleveland, TGNC affirming services are available at the Pride Network at MetroHealth, Cleveland Clinic's Center for LGBT Care, and University Hospital's navigator program. ECHO community partners receive technical assistance from experts in the field, but these are not necessarily informed by TGNC community input. Almost no other academic program is asking TGNC people what issues to prioritize, and no other program in the Cleveland area, to our knowledge. TGNC individuals are often research subjects and not recognized as experts themselves. Alpert's online survey asks LGBTQ+ individuals what they feel doctors should say and do, but the interaction is still mediated through an academic expert. The intervention closest to what is proposed is the Transgender Law's "Organizing for Transgender Healthcare: A Guide for Community Clinic Organizing and Activism", which defines transgender health care as "culturally appropriate primary health care, including access to sex-specific and transition-related procedures". In a case study in Los Angeles, a group of trans men formed an advocacy group (C3) that engaged with two community clinics to improve the clinics' cultural competency, medical forms, outreach materials, protocols for accessing hormones, and the referral process. This project is being proposed by cisgender women but is designed to be driven by TGNC individuals as partners and advocates navigating the healthcare system. In comparison to the model of C3 in Los Angeles, this project is innovative in that it calls for a sustained dialogue between the TGNC cohort and the health care providers and reaches a cross-section of practitioners from clinics that provide primary care.
METHODS: Over the course of the grant year, each step of the project is divided into three month portions. The first quarter will be dedicated to recruiting and forming a cohort of TGNC individuals, drawn mostly from the LGBT Center's extensive contact lists and centrality within the TGNC population. The investigators plan on recruiting 20 individuals to ensure the study meets the minimum retention of 12 subjects throughout the study needed for qualitative saturation, and individuals between 14-18 years of age will be able to participate with guardian permission. Interested individuals will fill out applications to identify their interests and ability to commit to the project and will allow us to create a cohort that reflects the diversity of the TGNC community in Cuyahoga County, including gender identity, types of gender-affirmative care required (including whether or not someone is considering, in the process of, or completed physical transition), racial and ethnic identity, age (over 14), and socio-economic class. Upon accepting the invitation to participate, each member of the cohort will complete a pretest that will elicit data on their experiences in the healthcare system, their knowledge of basic and transgender-specific medical terminology, their familiarity with healthcare providers in Cuyahoga County, and the likelihood of seeking care under a number of conditions (acute, chronic, moderate, severe). The investigators expect this to take one month. The following two months will consist of meeting as a cohort twice a month. The first two meetings will be dedicated to understanding the group's collective experiences with health care, what they would like to see change, and what strategies can be used to accomplish those ends. The investigators recognize that TGNC people come from a variety of backgrounds and each will bring their own strengths, networks, and perspectives to the table which will allow us to make full use of the indigenous expertise of the group. In consultation with the Nursing School of CWRU, the investigators will develop a health literacy training that meets the expressed needs of the cohort and Jesse Honsky will present it during the 3rd meeting. The goal here is not to provide all possible health education but rather to arm the cohort with the skills and language to empower them to act as advocates on their own behalf when navigating the healthcare system. The final meeting (the 4th) in this first quarter will be with a trained facilitator (Shemariah Arki) who will, under the direction of the TGNC cohort, plan a series of three interactive dialogues between the TGNC cohort and the healthcare providers. By meeting with the TGNC cohort first, without the healthcare providers, the TGNC cohort will have the opportunity to ensure the dialogues are designed to meet their objectives. Individual healthcare practitioners and medical staff will be recruited during the first quarter from the aforementioned clinics. The investigators will recruit at least twelve providers and twelve staff members. In the second quarter, the investigators will conduct a pretest that will collect data on attitudes towards TGNC individuals, TGNC-specific healthcare concerns, depth and breadth of referral networks for TGNC providers. Once the healthcare provider group is solidified, the LGBT Center will host three evening meetings (once per month) with the trained facilitator wherein TGNC individuals lead a conversation about what they see as barriers to their care, how they would like to be treated, and what they want healthcare providers to know about them as people. The first two meetings will be with healthcare practitioners and the final meeting will be medical staff so that the meetings can be more specific and without the interference of power dynamics within the provider groups. During this second quarter, the TGNC cohort will continue to meet on its own once a month to debrief from meetings, respond to what they have learned so far, and possibly refine the strategies for future meetings with healthcare providers as the series goes forward. At the end of the three months of dialogue, each participant, from both the TGNC cohort and healthcare provider, will be given a post-test to measure changes in attitude, practice, and knowledge. Participants will also have the opportunity to engage in a reflective interview.
The third quarter will diverge onto two different paths: the LGBT Center project coordinator will continue to engage with the cohort as they shift into the role of peer educators and advocates with other members of the TGNC community that interact at the LGBT Center. Luminais will conduct follow-up interviews with any TGNC cohort member that notifies the researchers that they have sought medical care and with any healthcare provider that notifies the researchers that they have had a clinical interaction with a TGNC individual. The investigators will not be seeking any protected medical information or the identity of patients, in the case of healthcare providers, but rather a discussion of the ease or difficulty in communication, levels of comfort, and comparison with other interactions in general.
Throughout the process, both Luminais and the LGBT Center coordinator will be engaged in participant observation and keep detailed field notes on all the meetings. All interviews will be transcribed; interviews and field notes will be coded with a priori codes derived from the literature on reducing health disparities and TGNC-specific health care by a research assistant. Pre- and post-tests will be analyzed to determine the success of facilitated dialogue in improving confidence and knowledge by both the TGNC cohort and the healthcare providers, and depending on sample size, the investigators will determine if there are any statistically significant changes. This analysis and write up will encompass the last quarter of the project.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TGNC Cohort
The Translate Study developed a cohort of transgender and gender non-conforming individuals (referred to here as TGNC cohort) and held three facilitated dialogue sessions with healthcare providers and staff (referred to here as healthcare participants). The overall goal of the Translate Study was to improve quality of life by reducing health disparities suffered by transgender and gender nonconforming (TGNC) individuals and by increasing their access to and use of primary health care.
TGNC Directed Advocacy Meetings
Series of 18 meetings with TGNC cohort, including 3 facilitated dialogues with the healthcare participants, to articulate barriers to access and to enter into dialogue with medical providers and staff.
Facilitated Dialogues between TGNC Cohort and Healthcare Participants
Healthcare Participants attend a facilitated dialogue with the TGNC cohort. 3 total facilitated dialogues were held, but each healthcare participant attends only 1 session.
Healthcare Participants
The Translate Study held three facilitated dialogue sessions between the TGNC Cohort and a group of healthcare participants, identified as physicians, nurse practitioners, registered nurses, students, physician assistants, and non-provider staff positions. Non-providers included healthcare administrative positions, rehabilitation, and vocational services.
Facilitated Dialogues between TGNC Cohort and Healthcare Participants
Healthcare Participants attend a facilitated dialogue with the TGNC cohort. 3 total facilitated dialogues were held, but each healthcare participant attends only 1 session.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TGNC Directed Advocacy Meetings
Series of 18 meetings with TGNC cohort, including 3 facilitated dialogues with the healthcare participants, to articulate barriers to access and to enter into dialogue with medical providers and staff.
Facilitated Dialogues between TGNC Cohort and Healthcare Participants
Healthcare Participants attend a facilitated dialogue with the TGNC cohort. 3 total facilitated dialogues were held, but each healthcare participant attends only 1 session.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* fluent English speaker
* above the age of 14 years old
* Currently employed as a medical provider or medical staff
* At least 18 years old
* fluent English speaker
Exclusion Criteria
* below the age of 14 years old
* does not identify as transgender or gender nonconforming
* Not currently employed as a medical provider or medical staff
* non-fluent English speaker
* below the age of 18 years old
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
LGBT Community Center of Greater Cleveland
OTHER
MetroHealth Medical Center
OTHER
Case Western Reserve University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel J Flannery, PhD
Role: STUDY_CHAIR
Director, Begun Center for Violence Prevention Research and Education; Jack, Joseph and Morton Mandel School of Applied Social Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
LGBT Community Center of Greater Cleveland
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-2018-2194
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.